These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1847848)

  • 1. A hepatobiliary study with Tc-99m N-pyridoxyl-5-methyltryptophan (PMT) in a patient with hepatoblastoma.
    Ohshiro K; Hanashiro Y; Shimabukuro K; Hori A; Nagata Y; Matsumoto H; Uchima H
    Clin Nucl Med; 1991 Jan; 16(1):10-2. PubMed ID: 1847848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
    Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
    J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of factors affecting uptake of Tc-99m Sn-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma.
    Hasegawa Y; Nakano S; Sobue T; Fujita M; Ishiguro S; Sasaki Y; Imaoka S; Tanaka S; Kasugai H; Inoue A
    Ann Nucl Med; 1994 May; 8(2):139-45. PubMed ID: 7521195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging.
    Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Noguchi A; Sasaki Y; Imaoka S; Fujita M; Kawamoto S; Kasugai H
    Cancer; 1986 Jan; 57(2):230-6. PubMed ID: 2417674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
    Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K
    Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small hepatocellular carcinoma visualized with technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan.
    Narabayashi I; Hamada T; Aoki O; Suematsu T
    Ann Nucl Med; 1987 Sep; 1(1):39-42. PubMed ID: 2856317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of uptake of technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis.
    Hasegawa Y; Nakano S; Hiyama T; Sobue T; Yoshida H; Sasaki Y; Imaoka S; Inoue A; Tanaka S; Kusagai H
    J Nucl Med; 1991 Feb; 32(2):228-35. PubMed ID: 1846910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of delayed imaging with Tc-99m PMT and Tc-99m DEIDA for visualization of hepatoma.
    Hasegawa Y; Nakano S; Hashizume T; Noguchi A; Ibuka K; Kasugai H; Kojima J; Ishigami S
    Clin Nucl Med; 1989 Jul; 14(7):526-31. PubMed ID: 2548797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of 99mTc-N-pyridoxyl-5-methyltryptophan hepatobiliary scintigraphy in hepatocellular carcinoma].
    Kashiwagi T; Azuma M; Matsuda H; Yoshioka H; Ishizu H; Mitsutani N; Koizumi T; Kobayashi Y
    Nihon Shokakibyo Gakkai Zasshi; 1985 Sep; 82(9):2061-7. PubMed ID: 2419606
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of delayed hepatobiliary imaging using 99mTc-Sn-N-pyridoxyl-5-methyltryptophan and 67Ga-citrate imaging for diagnosis of hepatocellular carcinoma.
    Hasegawa Y; Nakano S; Ishiguro S; Imaoka S; Sasaki Y; Tanaka S; Kasugai H; Kojima J; Ishigami S
    Eur J Nucl Med; 1988; 14(7-8):414-8. PubMed ID: 2846309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of 99mTc-(Sn)-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in diagnosis of hepatoma].
    Hasegawa Y; Nakano S; Noguchi A; Hashizume T; Ibuka K; Sasaki Y; Imaoka M; Kozima J; Ishigami S
    Kaku Igaku; 1983 Nov; 20(9):1355-9. PubMed ID: 6328071
    [No Abstract]   [Full Text] [Related]  

  • 12. [Delayed Tc-99m-PMT imaging in the specific diagnosis of hepatocellular carcinoma].
    Wu ZM
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):360-3. PubMed ID: 2854779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in the diagnosis of intrahepatic masses.
    Oyamada H; Yamazaki S; Makuuchi M; Hasegawa H
    Radioisotopes; 1989 May; 38(5):244-51. PubMed ID: 2546192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraosseous metastases of hepatocellular carcinoma detection and therapeutic assessment with Tc-99m PMT SPECT.
    Hayase N; Fukumoto M; Yoshida D; Kariya S; Akagi N; Kurohara A; Hisa N; Yoshida S
    Clin Nucl Med; 1999 May; 24(5):326-9. PubMed ID: 10232470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis of hepatocellular carcinoma to the colon demonstrated by Tc-99m PMT scintigraphy.
    Fukui H; Kashiwagi T; Shirai Y; Matsuda Y; Kawata S; Nishimura T; Kozuka T
    Clin Nucl Med; 1993 Jun; 18(6):512-5. PubMed ID: 8391407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical efficacy of hepatobiliary scintigraphy using 99m Tc-N-pyridoxyl-5-methyltryptophan (PMT)].
    Aburano T; Ohguchi M; Kuwajima A; Tonami N; Hisada K
    Kaku Igaku; 1983 Apr; 20(3):353-60. PubMed ID: 6632363
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental and clinical studies of hepatobiliary scintigraphy using 99mTc-N-pyridoxyl-5-methyltryptophan(99mTc-PMT)].
    Yoshida H; Kanamori I; Nakano S; Takeda I; Yasuda E; Matsuo S; Ichikawa H; Kimura T; Iwata F; Higuchi C
    Radioisotopes; 1983 Jul; 32(7):340-43. PubMed ID: 6658021
    [No Abstract]   [Full Text] [Related]  

  • 18. A new synthetic method for 99mTc labeled N-pyridoxyl-5-methyltryptophan as a hepatoma imaging agent.
    Zhou YG; Zhu T; Zhao HY; Wu ZM; Shi QX; Liang FH
    Int J Rad Appl Instrum B; 1987; 14(5):467-73. PubMed ID: 2822632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary scintigraphy and function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTC-PMT).
    Sugimura K; Nishiyama S; Narabayashi I
    Kobe J Med Sci; 1985 Apr; 31(2):85-94. PubMed ID: 4021432
    [No Abstract]   [Full Text] [Related]  

  • 20. Tc-99m PMT whole-body scintigraphy for evaluated of therapeutic effect and for monitoring bone metastasis in a patient with hepatocellular carcinoma.
    Sueyoshi K; Narabayashi I; Doi K; Takahashi M; Komori T; Tatsu Y; Tatsumi T; Utunomiya K; Uesugi Y; Adachi I; Shimizu T
    Clin Nucl Med; 2000 Dec; 25(12):1000-3. PubMed ID: 11129132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.